NEWARK, Del, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The preterm birth prevention and management market is poised for significant growth, with its size expected to increase from US$ 1.70 billion in 2024 to US$ 4.49 billion by 2034. Over the next decade, a promising 10.2% CAGR in the demand for preterm birth prevention and management is projected to drive this expansion.
The growing awareness and emphasis on maternal healthcare is a significant driver propelling the market expansion. As societies become increasingly conscious of the importance of women's health during pregnancy, there is a rising demand for effective solutions to prevent and manage preterm births.
Request a Sample of this Report Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-6457
Innovations in medical technology and research, such as proactive care and reactive treatments, are critical to the preterm birth prevention and management market's expansion. The field of preterm birth prevention is improved overall by ongoing research efforts that lead to the creation of novel therapies, diagnostic instruments, and treatment choices.
The market is growing significantly due to strategic actions taken by healthcare organizations and government entities to address the increasing prevalence of preterm births. The World Health Organization's prenatal care recommendations include important treatments, including nutrition counseling, nicotine and alcohol use counseling, and healthy diets to assist avoid premature delivery. With governments prioritizing the implementation of preventative measures and enhancing maternal healthcare service accessibility, the market is expected to rise steadily.
“The Asia Pacific is witnessing a significant upswing in the preterm birth prevention and management market. Growing emphasis on mother and child health, bettering healthcare facilities, and raising awareness all contribute to this growth. Proactive government initiatives and a growing awareness of the significance of preterm birth prevention and treatment in the region's healthcare ecosystem are projected to propel this market's consistent rise during the forecast period.” according Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Key Takeaways from the Preterm Birth Prevention and Management Market:
- Between 2019 and 2023, the preterm birth prevention and management industry size recorded a CAGR of 9.0%.
- The preterm birth prevention and management industry in India is estimated to witness prominent growth with a projected 12.8% CAGR from 2024 to 2034, driven by increased awareness and prioritization of maternal and child health
- China's preterm birth prevention and management industry is projected to follow closely with an estimated 11.5% CAGR through 2034, attributed to rising emphasis on research and innovation in the medical field.
- The preterm birth prevention and management market in the United States is likely to show a promising 8.1% CAGR between 2024 and 2034, influenced by technological innovations, rigorous healthcare research, and a societal emphasis on holistic well-being.
- Japan's preterm birth prevention and management industry is projected to develop at 12.1% CAGR through 2034, propelled by the country’s shift toward proactive healthcare measures.
- The Indonesia preterm birth prevention and management industry is likely to exhibit a 13.0% CAGR from 2024 to 2034, impacted by the integration of digital health solutions.
Click Here to Request Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-6457
Key Players and Strategies for Success in the Preterm Birth Prevention and Management Market
Here are some key strategies that players in the preterm birth prevention and management industry employ for success:
- Engage in partnerships with medical institutions to stay at the forefront
- Invest in research and development to create pioneering technologies and medications
- Establish connections with healthcare providers, policymakers, and organizations
- Stay well-informed of and comply with evolving regulatory standards to ensure product safety
Recent Developments in the Preterm Birth Prevention and Management Market
- Covis Pharma Group declared in April 2023 that it is going to discontinue Makena, the only medication authorized by the United States Food and Drug Administration to prevent premature delivery.
- The United States Food and Drug Administration authorized EYLEA® (aflibercept) Injection in February 2023 to treat preterm newborns with retinopathy of prematurity.
Top Key Preterm Birth Prevention and Management Market Players
- Aquatic Remedies Pvt. Ltd.
- Teva Pharmaceuticals USA, Inc.
- Anglo French Drugs & Industries Limited
- Biophar Lifesciences Pvt. Ltd.
- Jasco Labs (P) Ltd.
- BSA Pharma Inc.
- Pfizer Inc.
- Novartis AG
- Sanofi S.A
- AMAG Pharmaceuticals
- Mylan
Buy a Complete Research Report: https://www.futuremarketinsights.com/checkout/6457
Key Segments in the Preterm Birth Prevention and Management Market Report
By Therapy Type:
- Progesterone Therapy
- Corticosteroid Therapy
- Tocolytics Therapy
- Antihypertensive Therapy
- Magnesium Sulfate Therapy
- Heparin Prophylaxis Therapy
- Low-Dose Aspirin Therapy
- Antibiotics Therapy
By Route of Administration:
- Oral
- Parenteral
- Vaginal
By Patient Type:
- Prior Spontaneous PTB
- Preeclampsia
- Short Cervix
- Chronic Hypertension
- Insulin-dependent
- Twins
- Antiphospholipid Antibody Syndrome
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Mail Order Pharmacies
By Region:
- North America
- Europe
- Latin America
- South Asia
- East Asia
- Oceania
- Middle East and Africa
Have a Look at the Related Report from the Preterm Birth Prevention and Management Market:
Preterm Births and PROM Testing Market was valued at around US$ 1.7 Billion in 2021. With a projected CAGR of 3.2% for the next ten years, the market is likely to reach a valuation of nearly US$ 1.8 Billion by the end of 2032.
Tissue Diagnostics Market was valued at US$ 32.0 Bn in 2021 and is set to expand at a healthy CAGR of 12.8% during 2022-2032, with a market valuation of US$ 120.2 Bn by 2032.
Preterm Birth Diagnostic Test Kits Market sales worth U.S. $ 121.3 Mn in 2021 and will expand 1.6X over the forecast period. The market is anticipated to expand at a CAGR of 7.6% during the forecast period of 2022-2028
Cardiac Biomarker Diagnostic Test Kits Market size is projected to be worth US$ 1,950 million in 2023. The market is expected to surge at a CAGR of 5.1% during the forecast period 2023 to 2033
Birth Tissue Products Market sales of the market are anticipated to rise at a CAGR of 6.6% between 2023 and 2033, owing to the rising prevalence of various ophthalmic conditions.
Authored by:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
